Ergotamine-induced acute tubulo-interstitial nephritis

Maryam Pakfetrat; Akbar Rasekhi; Fatemeh Eftekhari; Nahid Hashemi; Jamshid Roozbeh; Simin Torabineghad; Leila Malekmakan

doi:10.4103/1319-2442.118100

Ergotamine-induced acute tubulo-interstitial nephritis

Saudi J Kidney Dis Transpl. 2013 Sep;24(5):981-3. doi: 10.4103/1319-2442.118100.

Authors

Maryam Pakfetrat¹, Akbar Rasekhi, Fatemeh Eftekhari, Nahid Hashemi, Jamshid Roozbeh, Simin Torabineghad, Leila Malekmakan

Affiliation

¹ Shiraz NephroUrology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 24029265
DOI: 10.4103/1319-2442.118100

Abstract

Ergotamine has been used for the treatment of migraine for many years, and its use in adults is considered to be safe and effective. In this report, we present a 22-year-old female patient, a known case of migraine, who was on ergotamine tartrate and presented with hypertension and renal failure. Renal biopsy indicated features of acute tubulo-interstitital nephritis.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Ergotamine / administration & dosage
Ergotamine / adverse effects*
Female
Humans
Kidney Glomerulus / pathology
Migraine Disorders / drug therapy
Nephritis, Interstitial / chemically induced*
Nephritis, Interstitial / pathology
Vasoconstrictor Agents / administration & dosage
Vasoconstrictor Agents / adverse effects*
Young Adult

Substances

Vasoconstrictor Agents
Ergotamine